Myriad Genetics (MYGN) EBT Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) EBT Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 12.58% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 64.58% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 15.14% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 56.92% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -6.81% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -27.03% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -15.03% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 16.39% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 7.29% |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | -15.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.99% |
| Dec 31, 2025 | 77.24% |
| Sep 30, 2025 | -23.58% |
| Jun 30, 2025 | -788.71% |
| Mar 31, 2025 | -13.51% |
| Dec 31, 2024 | -21.05% |
| Sep 30, 2024 | 65.36% |
| Jun 30, 2024 | 67.96% |
| Mar 31, 2024 | 50.76% |
| Dec 31, 2023 | 38.00% |
| Sep 30, 2023 | -38.46% |
| Jun 30, 2023 | -548.60% |
| Mar 31, 2023 | -99.24% |
| Dec 31, 2022 | -19.77% |
| Sep 30, 2022 | -211.06% |
| Jun 30, 2022 | -371.05% |
| Mar 31, 2022 | 46.77% |
| Dec 31, 2021 | 53.77% |
| Sep 30, 2021 | 117.06% |
| Jun 30, 2021 | 98.00% |